申请人:Bial-Portela & Cª, S.A.
公开号:US20150197503A1
公开(公告)日:2015-07-16
A process for preparing a substituted urea compound of Formula II or Formula I, or a pharmaceutically acceptable salt or ester thereof, Formula II, Formula I the process comprising the reaction of an intermediate of Formula II′ or Formula 1′, Formula II′, Formula I′ with a carbamoyl halide of the formula: R1R2NC(=0)Hal, in a solvent consisting essentially of pyridine, wherein Hal represents Cl, F, I or Br, and wherein ring A, and R1, R2, R5, V, W, X, Y and Z are as defined herein.
制备Formula II或Formula I的取代脲化合物的过程,或其药学上可接受的盐或酯,Formula II,Formula I的过程包括Formula II'或Formula I'中间体与卡巴莫酰卤化物的反应,Formula II',Formula I',其中卤素Hal代表Cl,F,I或Br,溶剂基本上由吡啶组成,其中环A,R1,R2,R5,V,W,X,Y和Z的定义如此。